Heimdall Insights

Global Spinal Muscular Atrophy Treatment Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Spinal Muscular Atrophy Treatment Market was valued at $5.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 17.2% CAGR, to an estimated market size of $10.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global Spinal Muscular Atrophy (SMA) treatment market encompasses the development, distribution, and administration of gene therapies, antisense oligonucleotides (ASOs), and small-molecule drugs designed to treat the underlying genetic causes or manage the symptoms of SMA. The scope includes FDA-approved disease-modifying therapies and emerging adjunct treatments, while excluding general supportive care and non-specific medical devices.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Spinal Muscular Atrophy Treatment Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

Segments

  • Gene Therapy
  • Antisense Oligonucleotides (ASO)
  • Small Molecule Drugs
  • Supportive & Adjunct Therapies